Table 5

Death rates stratified by MR evolution and post-TTVI MR degree

 MR stable (n = 197)MR improvement (n = 100)MR worsening (n = 32)P value
Death27 (13.7%)13 (13.0%)5 (15.6%)0.940
 MR stable (n = 197)MR improvement (n = 100)MR worsening (n = 32)P value
Death27 (13.7%)13 (13.0%)5 (15.6%)0.940
 None-to-mild MR (n = 251)Moderate MR (n = 65)Moderate-to-severe/severe MR (n = 13)P value
Death33 (13.2%)7 (10.8%)5 (38.5%)0.044
 None-to-mild MR (n = 251)Moderate MR (n = 65)Moderate-to-severe/severe MR (n = 13)P value
Death33 (13.2%)7 (10.8%)5 (38.5%)0.044

Bold values denote statistical significance at the p < 0.05 level.

Abbreviations: MR, mitral regurgitation; TTVI, transcatheter tricuspid valve interventions.

Table 5

Death rates stratified by MR evolution and post-TTVI MR degree

 MR stable (n = 197)MR improvement (n = 100)MR worsening (n = 32)P value
Death27 (13.7%)13 (13.0%)5 (15.6%)0.940
 MR stable (n = 197)MR improvement (n = 100)MR worsening (n = 32)P value
Death27 (13.7%)13 (13.0%)5 (15.6%)0.940
 None-to-mild MR (n = 251)Moderate MR (n = 65)Moderate-to-severe/severe MR (n = 13)P value
Death33 (13.2%)7 (10.8%)5 (38.5%)0.044
 None-to-mild MR (n = 251)Moderate MR (n = 65)Moderate-to-severe/severe MR (n = 13)P value
Death33 (13.2%)7 (10.8%)5 (38.5%)0.044

Bold values denote statistical significance at the p < 0.05 level.

Abbreviations: MR, mitral regurgitation; TTVI, transcatheter tricuspid valve interventions.

Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close